TipRanks
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)
:SUNPHARMA
India Market
SUNPHARMA
Sun Pharmaceutical Industries Limited
RESEARCH TOOLSreports
Want to see IN:SUNPHARMA full AI Analyst Report?

Sun Pharmaceutical Industries Limited (SUNPHARMA) Ratios

23 Followers

Sun Pharmaceutical Industries Limited Ratios

IN:SUNPHARMA's free cash flow for Q1 2027 was ₹0.55. For the 2027 fiscal year, IN:SUNPHARMA's free cash flow was decreased by ₹ and operating cash flow was ₹0.23. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 0.00 2.82 2.89 2.56 2.00
Quick Ratio
 0.00 2.31 2.33 1.95 1.47
Cash Ratio
 0.00 0.51 0.62 0.55 0.23
Solvency Ratio
 -0.18 0.58 0.68 0.65 0.50
Operating Cash Flow Ratio
 0.00 0.57 0.77 0.71 0.25
Short-Term Operating Cash Flow Coverage
 0.00 3.17 7.54 4.27 0.80
Net Current Asset Value
₹ 838.80B₹ 389.55B₹ 330.10B₹ 250.76B₹ 184.34B
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.04 0.03 0.04 0.09
Debt-to-Equity Ratio
 0.00 0.06 0.03 0.05 0.12
Debt-to-Capital Ratio
 0.00 0.05 0.03 0.05 0.11
Long-Term Debt-to-Capital Ratio
 0.00 <0.01 <0.01 <0.01 0.00
Financial Leverage Ratio
 0.00 1.30 1.28 1.34 1.44
Debt Service Coverage Ratio
 40.75 3.37 6.00 3.71 1.70
Interest Coverage Ratio
 37.77 39.99 169.28 102.42 148.94
Debt to Market Cap
 0.00 <0.01 <0.01 <0.01 0.03
Interest Debt Per Share
 1.52 20.68 10.54 14.64 29.33
Net Debt to EBITDA
 0.00 -0.38 -0.60 -0.47 0.19
Profitability Margins
Gross Profit Margin
55.75%55.70%78.02%76.41%74.21%
EBIT Margin
26.24%26.35%23.97%21.69%21.20%
EBITDA Margin
31.21%31.37%28.47%26.55%26.55%
Operating Profit Margin
22.93%23.18%52.90%50.36%49.91%
Pretax Profit Margin
26.69%25.77%26.13%22.78%21.33%
Net Profit Margin
20.19%19.64%20.79%19.75%19.31%
Continuous Operations Profit Margin
20.23%19.69%20.85%19.82%19.40%
Net Income Per EBT
75.65%76.21%79.56%86.67%90.52%
EBT Per EBIT
116.38%111.14%49.39%45.24%42.73%
Return on Assets (ROA)
0.00%10.55%11.87%11.21%10.49%
Return on Equity (ROE)
14.96%13.74%15.13%15.04%15.13%
Return on Capital Employed (ROCE)
0.00%15.73%37.64%35.67%36.00%
Return on Invested Capital (ROIC)
0.00%11.46%29.25%29.73%29.67%
Return on Tangible Assets
0.00%13.44%14.74%14.04%13.51%
Earnings Yield
2.80%2.72%2.68%2.45%3.59%
Efficiency Ratios
Receivables Turnover
 0.00 3.76 4.03 4.31 3.83
Payables Turnover
 0.00 3.53 1.87 2.02 1.99
Inventory Turnover
 0.00 2.25 1.13 1.11 1.08
Fixed Asset Turnover
 0.00 4.68 4.67 4.29 3.87
Asset Turnover
 0.00 0.54 0.57 0.57 0.54
Working Capital Turnover Ratio
 2.91 1.55 1.73 2.09 2.32
Cash Conversion Cycle
 0.00 155.77 218.74 232.81 251.09
Days of Sales Outstanding
 0.00 97.16 90.57 84.75 95.29
Days of Inventory Outstanding
 0.00 161.96 323.47 328.40 339.02
Days of Payables Outstanding
 0.00 103.35 195.29 180.34 183.22
Operating Cycle
 0.00 259.13 414.04 413.15 434.31
Cash Flow Ratios
Operating Cash Flow Per Share
 19.93 53.51 58.71 50.58 20.67
Free Cash Flow Per Share
 9.97 38.49 49.83 41.40 11.98
CapEx Per Share
 9.95 15.03 8.88 9.18 8.69
Free Cash Flow to Operating Cash Flow
 0.50 0.72 0.85 0.82 0.58
Dividend Paid and CapEx Coverage Ratio
 1.29 1.70 2.45 2.38 1.08
Capital Expenditure Coverage Ratio
 2.00 3.56 6.61 5.51 2.38
Operating Cash Flow Coverage Ratio
 0.00 2.78 5.96 3.71 0.72
Operating Cash Flow to Sales Ratio
 0.08 0.22 0.27 0.25 0.11
Free Cash Flow Yield
0.55%2.19%2.93%2.54%1.22%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 35.73 36.76 37.24 40.82 27.84
Price-to-Sales (P/S) Ratio
 7.21 7.22 7.74 8.06 5.37
Price-to-Book (P/B) Ratio
 5.15 5.05 5.64 6.14 4.21
Price-to-Free Cash Flow (P/FCF) Ratio
 180.61 45.66 34.08 39.35 82.08
Price-to-Operating Cash Flow Ratio
 90.38 32.84 28.93 32.21 47.56
Price-to-Earnings Growth (PEG) Ratio
 2.18 7.62 2.61 3.14 0.18
Price-to-Fair Value
 5.15 5.05 5.64 6.14 4.21
Enterprise Value Multiple
 23.11 22.63 26.60 29.89 20.44
Enterprise Value
 4.32T 4.15T 3.98T 3.85T 2.38T
EV to EBITDA
 23.11 22.63 26.60 29.89 20.44
EV to Sales
 7.21 7.10 7.57 7.94 5.43
EV to Free Cash Flow
 180.61 44.90 33.33 38.75 82.87
EV to Operating Cash Flow
 90.38 32.29 28.29 31.72 48.02
Tangible Book Value Per Share
 349.60 251.92 227.50 207.73 172.03
Shareholders’ Equity Per Share
 349.60 347.98 301.32 265.35 233.38
Tax and Other Ratios
Effective Tax Rate
 0.24 0.24 0.20 0.13 0.09
Revenue Per Share
 249.70 243.43 219.38 202.13 182.91
Net Income Per Share
 50.41 47.80 45.60 39.91 35.32
Tax Burden
 0.76 0.76 0.80 0.87 0.91
Interest Burden
 1.02 0.98 1.09 1.05 1.01
Research & Development to Revenue
 0.06 0.06 0.06 0.06 0.05
SG&A to Revenue
 0.27 0.27 0.19 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.33 1.12 1.29 1.27 0.53
Currency in INR